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Herpes simplex virus (HSV) is a large double-stranded DNA virus that is replicated and transcribed in the nucleus of infected cells. The regulation of HSV gene expression is a model for coordinate transcriptional control in eukaryotic cells because there are at least three sequentially ordered gene families whose expression is temporally regulated in a cascade fashion (1, 2) . During the course of lytic infection, transcription ofthe five members ofthe immediate early gene family (a genes) is activated by Vmw 65 (3), a virionassociated protein that is transcribed late in the infectious cycle (4, 5) . These a gene sequences are transcribed in the presence of cycloheximide or anisomycin by the host RNA polymerase (2, (6) (7) (8) (9) . The a mRNAs are subsequently translated into five infected cell proteins (ICPs) designated ICP4, -0, -27, -22, and -47 (1, 2) . Studies with temperature-sensitive mutants have shown that at least one of these gene products, ICP4 , is required in an active form throughout the course of infection for expression ofthe second (J3) gene family (10, 11) .
Two other a genes, those encoding ICP22 (12) and ICP27 (13, 45) , have been examined in some detail. Interruption of the gene coding for ICP22 does not affect virus growth in cell culture (12) , whereas the presence of ICP27 appears to be required for expression of a late (y) gene (13, 45) . Attempts to ascribe functions to the two other a genes (ICPO and ICP47) have been hampered by an inability to isolate conditionally lethal mutants of these genes. Recently, short-term transfection expression systems have been used to demonstrate that isolated immediate early genes from both adenovirus and pseudorabies virus can transactivate virus and cell genes (14) (15) (16) .
In this study we have employed short-term transfection assays of HeLa cells to investigate the transactivation po (17) and data that are compatible with, but not identical to, our findings have been described by Everett (18) .
MATERIALS AND METHODS
Cells and Viruses. The viruses used in this study were D2, a TK-deletion mutant of HSV-1 (19) , and F (20) . All virus stocks were grown and titrated on Vero cells (21) . HeLa cells were grown in Dulbecco's modified Eagle's medium supplemented with 10o calf serum.
Plasmids. The pseudogene-TK deletion mutant pRB316, pGR150b, and pRB114 plasmids have been described (4, (22) (23) (24) . pRHP6 is a HSV-1 (KOS) Xho I-Djunction clone that contains sequences coding for ICP4 and the 5' ends of ICP0 and ICP47. pIGA-15 contains a HSV-1 (KOS) Sst I/EcoRV fragment that bears the sequence coding for ICP0. pIGA-30 contains the BamHI-B fragment from HSV-1 (KOS) that codes for ICP27 and the 3' end of ICP0. pIGA-31 contains the EcoRI/Sal I fragment from HSV-1 (KOS) that codes for ICP47. pIGAs -15, -30, and -31 are in pUC vectors (25) . See Fig. 1 for map locations of each sequence.
Plasmid DNA was extracted from bacteria as described (26) .
Transfection Procedure. HeLa cells were transfected with 15 jig of target DNA (pseudogene-TK) and a molar gene equivalent of IE-plasmid DNA as described (27) . The medium was removed and exchanged at 12-24 hr posttransfection and the cells were allowed to incubate for an additional [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] hr. To normalize for the delivery of transfected DNA, 5 pug of pSV2CAT (28) per dish was added to the cotransfection mixtures and chloramphenicol acetyltransferase (CAT) activity was assayed (28) . RNA Purification. RNA was purified by the guanidine thiocyanate/CsCl procedure as described (29) . Probe Preparation. mTP8, an M13mp8 recombinant phage, has been described (30) . Single-stranded M13 template DNA was purified according to the procedure of Heidecker et al. (31) . Uniformly labeled, single-stranded cDNA probes were synthesized as described by Hu and Messing (32) . S1 Nuclease Hybridization Assay. Twenty to 50 ,ug of total RNA was analyzed as described (30) . When quantitation was required the bands were cut from the gel and radioactivity was counted by liquid scintillation spectrometry.
RESULTS
Activation of at and (3 (Fig. 2a, lane C) . In contrast, removal of the cycloheximide permits translation of the a mRNAs that accumulate during the block (2, 7). These translation products, the a ICPs, transactivate the (3TK gene promoter (33, 34) . The level of the TK transcripts that accumulate after reversal is similar to the level found in the untreated culture at 12 hr postinfection (Fig. 2a, lanes B and D) . Thus, transcription from a TK gene containing its natural promoter is dependent on the prior synthesis of virus-specified a gene polypeptides, as it is during lytic infection (2, 33, 34) .
When RNA extracted from cells transfected with the a-TK chimera was examined by S1 nuclease analysis we demonstrated that (t) the a promoter is activated in the presence of cycloheximide (Fig. 2b, lane A) and (ii) transcripts originating from the a and 8 promoters are detected when transfected cells are infected in the absence of drug (Fig. 2b, lane B) . Thus, RNA from drug-treated cells protects only that portion of the probe that corresponds to the TK body present in the construction downstream from the a promoter (55 nt), whereas RNA from untreated cells protects this fragment of the probe and a region of the probe corresponding to the TK body that is present upstream from the a promoter and fused to the natural f8 promoter (75 nt). These results demonstrate that under these assay conditions an a promoter is recognized and transcribed in the absence of de novo virus-specified protein synthesis. This is similar to the way that a promoters are regulated during the course of infection (4).
Proc. Nad Acad Sd USA 82 (1985) Proc. NatL Acad Scd USA 82 (1985) 5267 Transactivation by a Plasmid Containing Four a Genes. To examine if any of the a genes from HSV would transactivate a , gene in a transient expression assay we first cotransfected HeLa cells with an equimolar amount of pGR150b, a plasmid containing the Bgl II HM fragment from HSV-2 333 (23), and a plasmid containing the sequences that encode the TK gene. Although pGR150b contains sequences exclusively from HSV-2, it was used in this first experiment because it carries the genes encoding the HSV-2 analogues of ICPs -4, -0, -27, and -22. Moreover, genetic experiments have established that, for the most part, the maps of HSV-1 and HSV-2 are colinear and that mutations in one of these viruses are readily complemented or rescued by sequences from the other (35, 36) . At 48 hr posttransfection, cells were harvested and total cellular RNA was extracted and analyzed for the presence of TK RNA sequences by Si nuclease analysis. In the absence of transacting transcription factors, the TK gene is only poorly transcribed under the conditions of this assay (30) . Fig. 3 reveals that the constitutive level of TK transcripts is near the lower limit of sensitivity of the SI nuclease assay. In addition, we note that in the presence of pGRl50b there is >1000-fold more TK RNA than in its absence (determined by excising the relevant bands from the gel and measuring the amount of 32p in Si nuclease-resistant probe by liquid scintillation spectrometry). Two conclusions are drawn from this result: (0 a genes can be expressed in HeLa cells in the absence of the virion-associated factor and (it) the product of at least one of these a genes can transactivate the TK gene, resulting in the stable accumulation of TK RNA.
Titration of Transactivation Activity. When HSV infects a cell each genome brings in two gene equivalents of the sequences that code for both ICPO and ICP4 but only a single copy of TK. Therefore, we asked if altering the ratio of effector gene to target sequence would change the level ofTK transcripts that accumulate during the short-term transfection assay. Cells were cotransfected with TK and different molar equivalents of pGR150b. RNA Ag of RNA was used in the hybridization reaction.
ized to RNA were excised from the gel and radioactivity was counted. Altering the ratio of a gene template (the effector molecule) to target (TK gene) results in the accumulation of increasing levels ofTK mRNA (Fig. 4) . Thus, the transactivator(s) specified by the gene(s) on pGRl5Ob appears to act as a positive regulator in a stoichiometric manner. Identification of Transactivating a Genes. To determine if any of these four a gene products was independently able to transactivate the TK gene, recombinant DNA plasmids containing each of the five a gene sequences were isolated, or constructed, from a bank of HSV-1 EcoRI fragments cloned in pBR325 (37) . Plasmids containing the promoter and coding sequences for each of these five a genes, along with flanking virus DNA (see Fig. 1 ), were cotransfected with a plasmid containing the TK gene. After 48 hr, RNA was isolated from the transfected cultures and analyzed for the presence of TK transcripts as described in the preceding experiment. Fig. 5 demonstrates that there is no increase above the constitutive level of stable TK transcripts when plasmids containing the sequences that code for either ICP22, ICP47, or ICP27 are cotransfected with TK DNA. In contrast, significant levels of stable TK RNA accumulate when HeLa cells are cotransfected with plasmids containing the sequences encoding either ICP4 or ICPO. Comparison of the level ofTK RNA that accumulates in cells cotransfected with these two a genes reveals that the plasmid containing ICPO is a more potent transactivator of the TK gene (7-to 10-fold greater) than is the ICP4-containing sequence. Neither of these two sequences transactivates the TK gene as effectively as pGRl5Ob. Moreover, we have consistently noted the appearance of abundant, TK-containing transcripts that initiate at upstream sites when cells are cotransfected with pIGA-15 and a plasmid containing a B-TK gene. From this experiment we conclude that the sequences encoding either ICP4 or ICPO are each capable of transactivating the TK gene from HSV-1 in the absence of other virus gene products.
DISCUSSION
The experiments described in this manuscript suggest a role for specific a genes in transactivation of HSV genes. Our results demonstrate that cotransfection of the HSV-1 genes coding for either ICPO or ICP4 with TK DNA results in the transactivation of the TK gene in the absence of other virus-specified gene products. This conclusion is based on experiments that demonstrate that increased levels of TK RNA (above the constitutive level) accumulate under the 10-2 10-1 Effector-to-target ratio FIG. 4. Influence ofaltering the effector-to-target ratio. RNA was isolated from cells cotransfected with varying ratios of pGR15Ob to TK [ranging from 4:1 to 4 X 1O-4 (molar gene equivalents)] in 10-fold increments. The total amounts of plasmid DNA were kept constant by adding varying amounts of pUC9 after 48 hr of incubation and analyzed for the presence of TK mRNA by S1 nuclease analysis. Bands corresponding to probe protected by TK mRNA were excised from the gel and the amount of 32p was determined. (17) . This conclusion differs from that reached by Everett (18) , who demonstrated transactivation of a gD-p globin chimera only when the sequences coding for both ICPO and ICP4 were present. However, these results can be reconciled. The apparent discrepancy might result from subtle differences in the secondary structure of the promoters for these two p genes. Recently, we compared the sequences present in the promoters of a number of p genes and concluded that they shared a common structural element. Specifically, each promoter contains a hyphenated palindrome with a dyad of symmetry that is approximately equidistant from the ATA box (30) . Although the promoter for gD is also composed in part of a hyphenated palindrome, subtle changes in structure, which result from the unique sequence of each promoter, might alter the specificity of the response to different transactivation signals. A recent analysis of the gD promoter failed to define a role for cis-acting control elements in its response to transactivation signals. The conclusion reached in this analysis suggested that the gD promoter, per se, was sufficient for transactivation (38) . In this respect it differs from TK, in which there are two contiguous and partially overlapping sequences that control constitutive transcription and transactivation (30, (39) (40) (41) . Thus, some HSV promoters might require a cooperative interaction between the a proteins specified by these two sequences (or perhaps other members of the a gene family), whereas other promoters (such as TK) might be transactivated, under the conditions of this assay, by either of these two a gene products.
The identification of transactivation functions for both ICPO and ICP4 constitutes a paradox because cells infected with tsK [a virus whose defect has been localized to a single nucleotide change in the sequence coding for ICP4 (42) ] at the restrictive temperature accumulate only a mRNAs and proteins (43) . Genes of the p family (e.g., TK) are not transcribed under these conditions (43 We cannot determine, from these experiments, what role ICPO plays in regulation of the cascade of macromolecular synthesis during the course of a lytic infection by HSV-1. Nevertheless, it is clear from the data presented in this paper that HSV-1 possesses more than one immediate early gene product that has the capacity to transactivate at least one P gene. Moreover, the a gene battery present on pGRl5Ob (from HSV-2) is more effective at transactivating the TK gene than plasmids containing either ICP4 or ICPO from HSV-1.
Whether this effect represents synergy between a genes, a greater transactivation potential by HSV-2 a genes, or enhanced transcription of the a genes present on pGRl5Ob is not known. Ultimately, it will be necessary to determine if these a gene products bind to, or recognize, specific regions in the promoters of the /8 genes or if they exert their effect(s) by interacting with, or modifying, RNA polymerase II to form a unique transcription complex in virus-infected cells.
We gratefully acknowledge the gifts of plasmids used in this work from Gary Hayward, Myron Levine, Roy Persson, Bernard Roizman, and Jim Smiley. We thank Tim Fichter for technical assistance and Hamish Young and Argiris Efstratiadis for critical reading of the manuscript. These studies were supported by Public Health Service Grants Al 19724 and CA 17477 to S.S. from the National Institutes of Health.
